Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea.

Trial Profile

Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Feb 2014

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Psoriasis; Sleep apnoea syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Jul 2012 Primary endpoint 'Apnea-hypopnea-index' has not been met.
    • 01 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Aug 2011 Planned end date changed from 1 Dec 2011 to 1 Sep 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top